The use of sterile maggots in wound debridement therapy (MDT) is a well-established practice in South Africa, Europe, and the United States of America, and has been applied since wartimes to heal wounds. Despite this, their application in wound healing is comparatively low compared to other methods of wound debridement (chemical or surgical) in South Africa.


However, the recent emergence of antimicrobial resistance has renewed an interest in maggot debridement therapy using the larvae of Lucilia sericata, and in this regard inqaba biotec and the University of Pretoria have entered into a partnership to expand the commercial production and use of sterile maggots for wound healing in South Africa.


For more information visit link below

UP and Inqaba Biotec are blazing the trail for maggot therapy in South Africa

Leave a Reply

Your email address will not be published. Required fields are marked *

Contact Details

Southern Africa

  • Inqaba Biotechnical Industries (Pty) Ltd.
  • PO Box 14356, Hatfield 0028
  • Pretoria, South Africa

  • Tel: +27 12 343 5829
  • Fax: +27 86 677 8409
  • E-mail:

East Africa

  • inqaba biotec East Africa Ltd.
  • PO Box 1846
  • Nairobi 00606, Kenya

  • Tel: +254 735 370 693
  • Fax: +27 86 677 8409
  • E-mail:

West Africa

  • inqaba biotec West Africa Ltd.
  • PMB 5320, Oyo Road, Ibadan 200001
  • Oyo State, Nigeria

  • Tel: +‎234 805 882 7272
  • Fax: +27 86 677 8409
  • E-mail: